← 產業報告目錄

Radiation Oncology Market Research Report Information by Type (External Beam Radiation Therapy and Internal Radiation Therapy), By Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck, and Others), By End-User (Hospitals & Clinics, Oncology Centers and Academic & Research Institutes) And by Region (North America, Europe, Asia-Pacific, and Rest of The World) –Market Forecast Till 2032

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2024-08-10頁數 176報告編號 MRFRPharma10828CR

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

Radiation Oncology Market Research Report Information by Type (External Beam Radiation Therapy and Internal Radiation Therapy), By Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck, and Others), By End-User (Hospitals & Clinics, Oncology Centers and Academic & Research Institutes) And by Region (North America, Europe, Asia-Pacific, and Rest of The World) –Market Forecast Till 2032 Market Dynamics In 2023 the Radiation Oncology Market is expected to be worth USD 8.23 billion. With a compound annual growth rate (CAGR) of 8.0% for the forecast period (2024 – 2032), the sector is expected to rise from USD 8.90 billion in 2024 to USD 16.51 billion by 2032. Market expansion is being driven by the acceptance of combination treatments including radiation oncology with surgery and chemotherapy as well as by the rising global cancer rates. The main driver of the radiation oncology market is the global increasing frequency of cancer driven by aging populations, changes in lifestyle, and environmental effects. Technological advances in radiation treatment—including but not limited to intensity-modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS), and proton therapy—which have greatly improved treatment accuracy and patient results—have driven market expansion. Furthermore, the growing frequency of combination treatments like radiation oncology combined with chemotherapy and surgery helps to expand the market by giving patients more complete and effective treatment choices. The fast growth of radiation oncology can be attributed in great part to the rising cancer incidence. The growing worldwide need for efficient treatment alternatives in response to the rising cancer incidence is driving expansion in the radiation oncology market. Insights on Market Segments The Radiation Oncology Market has split depending on the kind of product into internal and external beam radiation therapies. Price range has split the Radiation Oncology Market into Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer, and Others. Based on the end user, the market has been split into hospitals and clinics, oncology centers, academic and research institutes. Regional Analysis Regionally, the Radiation Oncology Market is broken out as North America, Europe, Asia-Pacific, and the Rest of the World. With an 8.2% CAGR throughout the projection period, North America is expected to reach over USD 7.24 billion by 2032 from having the highest market share in 2023. Still, Asia-Pacific is expected to expand at the highest CAGR of 8.4% during the next years. Driven by numerous unique elements particular to the North America radiation oncology market, it is experiencing significant expansion. One major factor is the increasing cancer incidence in North America. An aging population and changes in lifestyle help to explain the rise in cancer incidence, hence demand for radiation oncology treatments is growing. Driven by various unique elements particular to the area, the Europe radiation oncology market is poised for significant growth. One key factor is the growing cancer incidence all throughout Europe. The rising incidence of cancer has created a growing demand for advanced therapeutic techniques including radiation treatment. Driven by several region-specific variables, the radiation oncology market in the Asia Pacific area is expected to grow rather significantly. The growing cancer prevalence in the Asia-Pacific area is a major factor. Principal Participants Key companies in the Radiation Oncology Market include Varian Medical Systems, Inc. (US), Elekta (Sweden), Accuracy Incorporated. (US), IBA Radiopharma Solutions (Belgium), BD (US), Mevion Medical Systems (US), Nordion (Canada), NTP Radioisotopes Soc Ltd. (South Africa), Curium (France), and Reflexion (US).
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 20 2 MARKET INTRODUCTION 22 2.1 DEFINITION 22 2.2 SCOPE OF THE STUDY 22 2.3 RESEARCH OBJECTIVE 22 2.4 MARKET STRUCTURE 23 3 RESEARCH METHODOLOGY 24 3.1 OVERVIEW 24 3.2 DATA FLOW 25 3.2.1 DATA MINING PROCESS 26 3.3 PURCHASED DATABASE: 27 3.4 SECONDARY SOURCES: 28 3.4.1 SECONDARY RESEARCH DATA FLOW: 29 3.5 PRIMARY RESEARCH: 30 3.5.1 PRIMARY RESEARCH DATA FLOW: 31 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED 32 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE 32 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: 33 3.6.1 CONSUMPTION & NET TRADE APPROACH 33 3.6.2 REVENUE ANALYSIS APPROACH 33 3.7 DATA FORECASTING 34 3.7.1 DATA FORECASTING TECHNIQUE 34 3.8 DATA MODELING 35 3.8.1 MICROECONOMIC FACTOR ANALYSIS: 35 3.8.2 DATA MODELING: 36 3.9 TEAMS AND ANALYST CONTRIBUTION 38 4 MARKET DYNAMICS 39 4.1 INTRODUCTION 39 4.2 DRIVERS 40 4.2.1 GROWING INCIDENCE OF CANCER 40 4.2.2 TECHNOLOGICAL ADVANCEMENTS IN RADIATION THERAPY 41 4.2.3 RISING ADOPTION OF COMBINATION THERAPIES INVOLVING RADIATION ONCOLOGY ALONGSIDE SURGERY AND CHEMOTHERAPY 41 4.3 CHALLENGES 42 4.3.1 REGULATORY APPROVAL CHALLANGES 42 4.3.2 REIMBURSEMENT CONCERNS 43 4.3.3 LACK OF SKILLED RADIOTHERAPY PROFESSIONALS 44 4.4 OPPORTUNITY 45 4.4.1 GROWING EMPHASIS ON VALUE-BASED HEALTHCARE AND TREATMENT SOLUTIONS 45 4.4.2 RISING UTILIZATION OF ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING WITHIN THE FIELD OF RADIATION ONCOLOGY 45 5 MARKET FACTOR ANALYSIS 47 5.1 VALUE CHAIN ANALYSIS 47 5.1.1 PARTICIPANTS (AT DIFFERENT NODES) 47 5.1.1.1 RAW MATERIAL SUPPLIERS 47 5.1.1.2 MANUFACTURERS 48 5.1.1.3 DISTRIBUTION CHANNEL 48 5.1.1.4 END-USER 49 5.1.2 INTEGRATION LEVELS 49 5.1.3 KEY ISSUES ADDRESSED (KEY SUCCESS FACTORS) 50 5.2 PORTER’S FIVE FORCES MODEL 51 5.2.1 BARGAINING POWER OF SUPPLIERS 51 5.2.2 BARGAINING POWER OF BUYERS 52 5.2.3 THREAT OF NEW ENTRANTS 52 5.2.4 THREAT OF SUBSTITUTES 53 5.2.5 INTENSITY OF RIVALRY 54 5.3 IMPACT ANALYSIS OF COVID-19 54 5.3.1 IMPACT ON OVERALL HEALTHCARE MARKET 54 5.3.1.1 ECONOMIC IMPACT 55 5.3.2 IMPACT ON GLOBAL RADIATION ONCOLOGY MARKET 55 5.3.3 IMPACT ON MARKET DEMAND 56 5.3.3.1 IMPACT DUE TO RESTRICTIONS/LOCKDOWN 56 5.3.3.2 CONSUMER SENTIMENTS 56 5.3.4 IMPACT ON PRICING 56 6 GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE 58 6.1 INTRODUCTION 58 6.2 EXTERNAL BEAM RADIATION THERAPY 59 6.2.1 LINEAR ACCELERATORS (LINAC) 60 6.2.1.1 GAMMA KNIFE 61 6.2.1.2 CYBERKNIFE 61 6.2.2 COBALT-60 SYSTEM 62 6.2.3 PARTICLE THERAPY SYSTEM 62 6.2.4 PROTON BEAM THERAPY SYSTEM 63 6.3 INTERNAL RADIATION THERAPY 63 6.3.1 SEEDS 64 6.3.2 AFTERLOADERS 64 6.3.3 INTRAOPERATIVE RADIOTHERAPY SYSTEMS 65 7 GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION 66 7.1 INTRODUCTION 66 7.2 PROSTATE CANCER 67 7.3 BREAST CANCER 68 7.4 LUNG CANCER 68 7.5 HEAD & NECK 69 7.6 OTHERS 69 8 GLOBAL RADIATION ONCOLOGY MARKET, BY END USER 71 8.1 INTRODUCTION 71 8.2 HOSPITALS & CLINICS 72 8.3 ONCOLOGY CENTERS 72 8.4 ACADEMIC & RESEARCH INSTITUTES 73 9 GLOBAL RADIATION ONCOLOGY MARKET, BY REGION 75 9.1 OVERVIEW 75 9.2 NORTH AMERICA 76 9.2.1 US 81 9.2.2 CANADA 83 9.3 EUROPE 85 9.3.1 GERMANY 90 9.3.2 FRANCE 92 9.3.3 UK 94 9.3.4 ITALY 96 9.3.5 SPAIN 98 9.3.6 REST OF EUROPE 100 9.4 ASIA PACIFIC 102 9.4.1 CHINA 106 9.4.2 JAPAN 108 9.4.3 INDIA 110 9.4.4 SOUTH KOREA 112 9.4.5 AUSTRALIA 114 9.4.6 REST OF ASIA PACIFIC 116 9.5 REST OF THE WORLD 118 9.5.1 MIDDLE EAST 123 9.5.2 AFRICA 125 9.5.3 LATIN AMERICA 127 10 COMPETITIVE LANDSCAPE 129 10.1 INTRODUCTION 129 10.2 COMPETITION DASHBOARD 129 10.2.1 PRODUCT PORTFOLIO 130 10.2.2 REGIONAL PRESENCE 130 10.2.3 STRATEGIC ALLIANCES 131 10.2.4 INDUSTRY EXPERIENCES 131 10.3 MARKET SHARE ANALYSIS, 2022 131 10.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL RADIATION ONCOLOGY MARKET 132 10.5 LIST OF KEY PLAYERS, BY COUNTRY 132 10.6 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL 133 10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 134 10.7.1 PRODUCT LAUNCH 134 10.7.2 PARTNERSHIP & COLLABORATION 137 10.7.3 EXPANSION & ACQUISITION 139 10.7.4 INVESTMENT 140 11 COMPANY PROFILES 141 11.1 VARIAN MEDICAL SYSTEMS, INC. 141 11.1.1 COMPANY OVERVIEW 141 11.1.2 FINANCIAL OVERVIEW 142 11.1.3 PRODUCTS OFFERED 143 11.1.4 KEY DEVELOPMENTS 143 11.1.5 SWOT ANALYSIS 144 11.1.6 KEY STRATEGY 144 11.2 ELEKTA 145 11.2.1 COMPANY OVERVIEW 145 11.2.2 FINANCIAL OVERVIEW 146 11.2.3 PRODUCTS OFFERED 147 11.2.4 KEY DEVELOPMENTS 147 11.2.5 SWOT ANALYSIS 147 11.2.6 KEY STRATEGY 148 11.3 ACCURACY INCORPORATED 148 11.3.1 COMPANY OVERVIEW 148 11.3.2 FINANCIAL OVERVIEW 150 11.3.3 PRODUCTS OFFERED 151 11.3.4 KEY DEVELOPMENTS 151 11.3.5 SWOT ANALYSIS 153 11.3.6 KEY STRATEGY 153 11.4 IBA RADIOPHARMA SOLUTIONS 155 11.4.1 COMPANY OVERVIEW 155 11.4.2 FINANCIAL OVERVIEW 156 11.4.3 PRODUCTS OFFERED 157 11.4.4 KEY DEVELOPMENTS 157 11.4.5 SWOT ANALYSIS 158 11.4.6 KEY STRATEGY 158 11.5 BD 160 11.5.1 COMPANY OVERVIEW 160 11.5.2 FINANCIAL OVERVIEW 161 11.5.3 PRODUCTS OFFERED 162 11.5.4 SWOT ANALYSIS 162 11.5.5 KEY STRATEGY 162 11.6 MEVION MEDICAL SYSTEMS 163 11.6.1 COMPANY OVERVIEW 163 11.6.2 PRODUCTS OFFERED 164 11.6.3 KEY DEVELOPMENTS 164 11.6.4 SWOT ANALYSIS 165 11.6.5 KEY STRATEGY 165 11.7 NORDION 167 11.7.1 COMPANY OVERVIEW 167 11.7.2 FINANCIAL OVERVIEW 168 11.7.3 PRODUCTS OFFERED 168 11.7.4 KEY DEVELOPMENTS 168 11.7.5 SWOT ANALYSIS 168 11.7.6 KEY STRATEGY 169 11.8 NTP RADIOISOTOPES SOC LTD 170 11.8.1 COMPANY OVERVIEW 170 11.8.2 PRODUCTS OFFERED 171 11.8.3 KEY DEVELOPMENTS 171 11.8.4 SWOT ANALYSIS 171 11.8.5 KEY STRATEGY 172 11.9 CURIUM 173 11.9.1 COMPANY OVERVIEW 173 11.9.2 PRODUCTS OFFERED 174 11.9.3 KEY DEVELOPMENTS 174 11.9.4 SWOT ANALYSIS 175 11.9.5 KEY STRATEGY 175 11.10 REFLEXION 176 11.10.1 COMPANY OVERVIEW 176 11.10.2 PRODUCTS OFFERED 177 11.10.3 KEY DEVELOPMENTS 177 11.10.4 SWOT ANALYSIS 177 11.10.5 KEY STRATEGY 178
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 36 TABLE 2 GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 59 TABLE 3 GLOBAL RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 60 TABLE 4 GLOBAL RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 61 TABLE 5 GLOBAL RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 64 TABLE 6 GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 66 TABLE 7 GLOBAL RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 71 TABLE 8 GLOBAL RADIATION ONCOLOGY MARKET, BY REGION, 2019-2032 (USD BILLION) 75 TABLE 9 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY COUNTRY, 2019-2032 (USD BILLION) 78 TABLE 10 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 78 TABLE 11 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 79 TABLE 12 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 79 TABLE 13 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 79 TABLE 14 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 80 TABLE 15 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 80 TABLE 16 US RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 81 TABLE 17 US RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 81 TABLE 18 US RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 81 TABLE 19 US RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 82 TABLE 20 US RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 82 TABLE 21 US RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 82 TABLE 22 CANADA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 83 TABLE 23 CANADA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 83 TABLE 24 CANADA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 83 TABLE 25 CANADA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 84 TABLE 26 CANADA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 84 TABLE 27 CANADA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 84 TABLE 28 EUROPE RADIATION ONCOLOGY MARKET, BY COUNTRY, 2019-2032 (USD BILLION) 87 TABLE 1 EUROPE RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 88 TABLE 2 EUROPE RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 88 TABLE 3 EUROPE RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 88 TABLE 4 EUROPE RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 89 TABLE 5 EUROPE RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 89 TABLE 6 EUROPE RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 89 TABLE 7 GERMANY RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 90 TABLE 8 GERMANY RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 90 TABLE 9 GERMANY RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 90 TABLE 10 GERMANY RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 91 TABLE 11 GERMANY RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 91 TABLE 12 GERMANY RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 91 TABLE 13 FRANCE RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 92 TABLE 14 FRANCE RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 92 TABLE 15 FRANCE RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 92 TABLE 16 FRANCE RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 93 TABLE 17 FRANCE RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 93 TABLE 18 FRANCE RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 93 TABLE 19 UK RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 94 TABLE 20 UK RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 94 TABLE 21 UK RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 94 TABLE 22 UK RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 95 TABLE 23 UK RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 95 TABLE 24 UK RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 95 TABLE 25 ITALY RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 96 TABLE 26 ITALY RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 96 TABLE 27 ITALY RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 96 TABLE 28 ITALY RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 97 TABLE 29 ITALY RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 97 TABLE 30 ITALY RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 97 TABLE 31 SPAIN RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 98 TABLE 32 SPAIN RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 98 TABLE 33 SPAIN RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 98 TABLE 34 SPAIN RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 99 TABLE 35 SPAIN RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 99 TABLE 36 SPAIN RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 99 TABLE 37 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 100 TABLE 38 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 100 TABLE 39 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 100 TABLE 40 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 101 TABLE 41 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 101 TABLE 42 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 101 TABLE 43 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY COUNTRY, 2019-2032 (USD BILLION) 103 TABLE 44 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 104 TABLE 45 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 104 TABLE 46 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 104 TABLE 47 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 105 TABLE 48 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 105 TABLE 49 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 105 TABLE 50 CHINA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 106 TABLE 51 CHINA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 106 TABLE 52 CHINA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 106 TABLE 53 CHINA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 107 TABLE 54 CHINA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 107 TABLE 55 CHINA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 107 TABLE 56 JAPAN RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 108 TABLE 57 JAPAN RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 108 TABLE 58 JAPAN RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 108 TABLE 59 JAPAN RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 109 TABLE 60 JAPAN RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 109 TABLE 61 JAPAN RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 109 TABLE 62 INDIA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 110 TABLE 63 INDIA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 110 TABLE 64 INDIA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 110 TABLE 65 INDIA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 111 TABLE 66 INDIA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 111 TABLE 67 INDIA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 111 TABLE 68 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 112 TABLE 69 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 112 TABLE 70 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 112 TABLE 71 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 113 TABLE 72 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 113 TABLE 73 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 113 TABLE 74 AUSTRALIA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 114 TABLE 75 AUSTRALIA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 114 TABLE 76 AUSTRALIA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 114 TABLE 77 AUSTRALIA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 115 TABLE 78 AUSTRALIA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 115 TABLE 79 AUSTRALIA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 115 TABLE 80 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 116 TABLE 81 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 116 TABLE 82 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 116 TABLE 83 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 117 TABLE 84 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 117 TABLE 85 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 117 TABLE 86 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY COUNTRY, 2019-2032 (USD BILLION) 120 TABLE 87 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 121 TABLE 88 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 121 TABLE 89 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 121 TABLE 90 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 122 TABLE 91 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 122 TABLE 92 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 122 TABLE 93 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 123 TABLE 94 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 123 TABLE 95 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 123 TABLE 96 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 124 TABLE 97 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 124 TABLE 98 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 124 TABLE 99 AFRICA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 125 TABLE 100 AFRICA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 125 TABLE 101 AFRICA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 125 TABLE 102 AFRICA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 126 TABLE 103 AFRICA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 126 TABLE 104 AFRICA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 126 TABLE 105 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 127 TABLE 106 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 127 TABLE 107 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 127 TABLE 108 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 128 TABLE 109 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 128 TABLE 110 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 128 TABLE 111 PRODUCT LAUNCH 134 TABLE 112 PARTNERSHIP & COLLABORATION 137 TABLE 113 EXPANSION & ACQUISITION 139 TABLE 114 INSTRUMENT 140 TABLE 115 VARIAN MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED 143 TABLE 116 ELEKTA: PRODUCTS OFFERED 147 TABLE 117 ACCURACY INCORPORATED: PRODUCTS OFFERED 151 TABLE 118 ACCURACY INCORPORATED: KEY DEVELOPMENTS 151 TABLE 119 IBA RADIOPHARMA SOLUTIONS: PRODUCTS OFFERED 157 TABLE 120 IBA RADIOPHARMA SOLUTIONS: KEY DEVELOPMENTS 157 TABLE 121 BD: PRODUCTS OFFERED 162 TABLE 122 MEVION MEDICAL SYSTEMS: PRODUCTS OFFERED 164 TABLE 123 MEVION MEDICAL SYSTEMS: KEY DEVELOPMENTS 164 TABLE 124 NORDION: PRODUCTS OFFERED 168 TABLE 125 NTP RADIOISOTOPES SOC LTD: PRODUCTS OFFERED 171 TABLE 126 CURIUM: PRODUCTS OFFERED 174 TABLE 127 REFLEXION: PRODUCTS OFFERED 177 LIST OF FIGURES FIGURE 1 GLOBAL RADIATION ONCOLOGY MARKET: STRUCTURE 23 FIGURE 2 GLOBAL RADIATION ONCOLOGY MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032) 39 FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 42 FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032) 44 FIGURE 5 SUPPLY CHAIN ANALYSIS: GLOBAL RADIATION ONCOLOGY MARKET 47 FIGURE 6 PORTER’S FIVE FORCES MODEL: GLOBAL RADIATION ONCOLOGY MARKET 51 FIGURE 7 GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE, SEGMENT ATTRACTIVENESS ANALYSIS 58 FIGURE 8 GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE, 2022 (% SHARE) 59 FIGURE 9 GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION, SEGMENT ATTRACTIVENESS ANALYSIS 66 FIGURE 10 GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION, 2022 (% SHARE) 67 FIGURE 11 GLOBAL RADIATION ONCOLOGY MARKET, BY END USER, SEGMENT ATTRACTIVENESS ANALYSIS 71 FIGURE 12 GLOBAL RADIATION ONCOLOGY MARKET, BY END USER, 2022 (% SHARE) 72 FIGURE 13 GLOBAL RADIATION ONCOLOGY MARKET, BY REGION, 2022 (% SHARE) 75 FIGURE 14 NORTH AMERICA MARKET: SWOT ANALYSIS 77 FIGURE 15 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY COUNTRY, 2022 (% SHARE) 78 FIGURE 16 EUROPE RADIATION ONCOLOGY MARKET, BY COUNTRY, 2022 (% SHARE) 86 FIGURE 17 EUROPE MARKET: SWOT ANALYSIS 87 FIGURE 18 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY COUNTRY, 2022 (% SHARE) 102 FIGURE 19 ASIA PACIFIC MARKET: SWOT ANALYSIS 103 FIGURE 20 ROW RADIATION ONCOLOGY MARKET, BY COUNTRY, 2022 (% SHARE) 119 FIGURE 21 REST OF THE WORLD MARKET: SWOT ANALYSIS 120 FIGURE 22 COMPETITOR DASHBOARD: GLOBAL RADIATION ONCOLOGY MARKET 130 FIGURE 23 GLOBAL RADIATION ONCOLOGY MARKET: COMPETITIVE ANALYSIS, 2022 131 FIGURE 24 VARIAN MEDICAL SYSTEMS, INC.: FINANCIAL OVERVIEW SNAPSHOT 142 FIGURE 25 VARIAN MEDICAL SYSTEMS, INC.: SWOT ANALYSIS 144 FIGURE 26 ELEKTA: SWOT ANALYSIS 147 FIGURE 27 ACCURACY INCORPORATED: SWOT ANALYSIS 153 FIGURE 28 IBA RADIOPHARMA SOLUTIONS: SWOT ANALYSIS 158 FIGURE 29 BD: SWOT ANALYSIS 162 FIGURE 30 MEVION MEDICAL SYSTEMS: SWOT ANALYSIS 165 FIGURE 31 NORDION: SWOT ANALYSIS 168 FIGURE 32 NTP RADIOISOTOPES SOC LTD: SWOT ANALYSIS 171 FIGURE 33 CURIUM: SWOT ANALYSIS 175 FIGURE 34 REFLEXION: SWOT ANALYSIS 177

提及公司

Varian Medical SystemsInc. (US)Elekta (Sweden)Accuracy Incorporated. (US)IBA Radiopharma Solutions (Belgium)BD (US)Mevion Medical Systems (US)Nordion (Canada)NTP Radioisotopes Soc Ltd. (South Africa)Curium (France)and Reflexion (US).

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們